methylprednisolone and Parkinsonian Disorders

methylprednisolone has been researched along with Parkinsonian Disorders in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (50.00)	29.6817
2010's	1 (16.67)	24.3611
2020's	2 (33.33)	2.80

Authors

Authors	Studies
Maikap, D; Mv, P; Padhan, P	1
Constantinides, VC; Deligianni, C; Dimitrakopoulos, A; Kapaki, E; Paraskevas, GP	1
Butler, M; Fanning, N; Harrington, H; Mok, TH; Saidha, S	1
Fabiani, G; Germiniani, FM; Sá, DS; Teive, HA; Werneck, LC	1
Chacón, J; García-Moreno, JM	1
Folgar, S; Gatto, EM; Micheli, F; Raina, G	1

Reviews

1 review(s) available for methylprednisolone and Parkinsonian Disorders

Article	Year
Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6 Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Humans; Levodopa; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Male; Methylprednisolone; Neurologic Examination; Parkinsonian Disorders; Prednisolone; Recurrence	2002

Article

Year

Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature.

Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6

Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Humans; Levodopa; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Male; Methylprednisolone; Neurologic Examination; Parkinsonian Disorders; Prednisolone; Recurrence

2002

Other Studies

5 other study(ies) available for methylprednisolone and Parkinsonian Disorders

Article	Year
Parkinsonism as the presenting manifestation of lupus: A case-based review. Lupus, 2023, Volume: 32, Issue:8 Topics: Female; Humans; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Middle Aged; Parkinsonian Disorders	2023
Lentiform fork sign in a patient with systemic lupus erythematosus. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021, Volume: 42, Issue:1 Topics: Aged; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Parkinsonian Disorders	2021
Multiple sclerosis exceptionally presenting as parkinsonism responds to intravenous methylprednisolone. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:5 Topics: Disease Progression; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Parkinsonian Disorders; Treatment Outcome	2010
Reversible parkinsonian syndrome in systemic and brain vasculitis. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:3 Topics: Adult; Anti-Inflammatory Agents; Electroencephalography; Female; Humans; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Methylprednisolone; Parkinsonian Disorders; Pulse Therapy, Drug; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vasculitis	2002
Parkinsonism as a manifestation of multiple sclerosis. Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:1 Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Methylprednisolone; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neurologic Examination; Parkinsonian Disorders	2003